Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer-Reference-Cited by-同舟云学术

Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer

Published:2021-04-01 Issue:4 Volume:7 Page:555
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Ali Adnan¹²³,Hoyle Alex¹²³⁴,Haran Áine M.¹²³⁴,Brawley Christopher D.⁵,Cook Adrian⁵,Amos Claire⁵,Calvert Joanna⁵,Douis Hassan⁶,Mason Malcolm D.⁷,Dearnaley David⁸,Attard Gerhardt⁹,Gillessen Silke¹⁰¹¹¹²,Parmar Mahesh K. B.⁵,Parker Christopher C.⁸,Sydes Matthew R.⁵,James Nicholas D.⁸,Clarke Noel W.¹²³⁴

Affiliation:

1. Genito-Urinary Cancer Research Group, Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom

2. FASTMAN Centre of Excellence, Manchester Cancer Research Centre, Manchester, United Kingdom

3. Department of Surgery, The Christie NHS Foundation Trust, Manchester, United Kingdom

4. Department of Urology, The Salford NHS Foundation Trust, Manchester, United Kingdom

5. MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, United Kingdom

6. Department of Radiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

7. Cardiff University, Cardiff, United Kingdom

8. Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom

9. UCL Cancer Institute, London, United Kingdom

10. Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom

11. Oncology Institute of Southern Switzerland, Bellinzona, Switzerland

12. Università della Svizzera Italiana, Lugano, Switzerland

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2776418/jamaoncology_ali_2021_oi_200113_1617385021.78094.pdf

Reference22 articles.

1. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.;Parker;Lancet,2018

2. Prostate radiotherapy for metastatic hormone-sensitive prostate cancer: a STOPCAP systematic review and meta-analysis.;Burdett;Eur Urol,2019

3. Effect on survival of androgen deprivation therapy alone compared to androgen deprivation therapy combined with concurrent radiation therapy to the prostate in patients with primary bone metastatic prostate cancer in a prospective randomised clinical trial: data from the HORRAD trial.;Boevé;Eur Urol,2019

4. Prostate cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up.;Parker;Ann Oncol,2020

5. Management of patients with advanced prostate cancer: report of the Advanced Prostate Cancer Consensus Conference 2019.;Gillessen;Eur Urol,2020

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biology-guided radiotherapy in metastatic prostate cancer: time to push the envelope?;Frontiers in Oncology;2024-09-09

2. Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study;The Lancet Oncology;2024-09

3. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer;European Urology;2024-08

4. Interlesional response heterogeneity is associated with the prognosis of abiraterone treatment in metastatic castration-resistant prostate cancer;Med;2024-08

5. Front-Line Therapeutic Strategy in Metastatic Hormone Sensitive Prostate Cancer: An Updated Therapeutic Algorithm;Clinical Genitourinary Cancer;2024-08